University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe.


  1. Home


  2. Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe.


  3. Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe.

rakerr2

Tunis S, Hanna E, Neumann PJ, Toumi M, Dabbous O, Drummond M, Fricke FU, Sullivan SD, Malone DC, Persson U, Chambers JD. Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe. Health Policy. 2021 Dec

Upcoming Events

Full Calendar

News Categories